RAF1 and breast carcinoma: The present study aimed to evaluate the correlation between MiRNA-106a gene expression and levels of Hb%, WBCs and platelets count as well as tumor marker proteins RAF-1 in a trial to check their early diagnostic and prognostic value which may help to understand their roles in breast cancer.